Inventor · disambiguated record
Eric Sievers
Also filed as: SIEVERS ERIC
16 granted patents·8 pending applications·213 citations·filing 2006–2024
94Inventor score
Top patents by PatentIndex Score
24 records- 0196US11077164B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEAGEN INC·Filed 2021·Granted Aug 3, 2021·3 cites·18 claims
- 0296US10940178B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEAGEN INC·Filed 2020·Granted Mar 9, 2021·4 cites·30 claims
- 0396US10722549B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Jul 28, 2020·7 cites·23 claims
- 0495US11369658B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEAGEN INC·Filed 2021·Granted Jun 28, 2022·2 cites·9 claims
- 0595US10912813B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEAGEN INC·Filed 2018·Granted Feb 9, 2021·5 cites·1 claims
- 0694US10098963B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Oct 16, 2018·10 cites·8 claims
- 0794US9713648B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2015·Granted Jul 25, 2017·11 cites·4 claims
- 0894US9211319B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSIEVERS ERIC·Filed 2010·Granted Dec 15, 2015·30 cites·17 claims
- 0994US7695716B2Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2008·Granted Apr 13, 2010·75 cites·38 claims
- 1092US10478469B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Nov 19, 2019·6 cites·30 claims
- 1192US8470329B2Combination therapy with antibody-drug conjugatesOFLAZOGLU EZOGELIN·Filed 2012·Granted Jun 25, 2013·21 cites·20 claims
- 1291US8758758B1Post-relapse treatment of CD30 expressing lymphomasSIEVERS ERIC·Filed 2011·Granted Jun 24, 2014·12 cites·17 claims
- 1391US2024415917A1Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugatesSEAGEN INC·Filed 2024·Application pending·0 cites
- 1489US8263083B2Combination therapy with antibody-drug conjugatesOFLAZOGLU EZOGELIN·Filed 2008·Granted Sep 11, 2012·24 cites·13 claims
- 1585US2024139275A1Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugatesSEAGEN INC·Filed 2022·Application pending·0 cites
- 1684US11559558B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEAGEN INC·Filed 2022·Granted Jan 24, 2023·0 cites·30 claims
- 1770US8808696B2Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion moleculesBROLY HERVE·Filed 2006·Granted Aug 19, 2014·2 cites·16 claims
- 1866US7842292B2Methods for treating B-cell malignancies using a TACI-Ig fusion moleculeARES TRADING SA·Filed 2006·Granted Nov 30, 2010·1 cites·19 claims
- 1964US2025161472A1Cancer treatment with a conditionally active anti-ror2 antibody-drug conjugateBIOATLA INC·Filed 2023·Application pending·0 cites
- 2058US2025276075A1Methods of treating axl-expressing cancers with anti-axl antibodies, antibody fragments and their immunoconjugatesBIOATLA INC·Filed 2021·Application pending·0 cites
- 2156US2011038856A1Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2007·Application pending·0 cites
- 2248US2025242012A1Gene delivery systemSYMVIVO CORP·Filed 2021·Application pending·0 cites
- 2344US2008025946A1Interleukin 21 and tyrosine kinase inhibitor combination therapySIVAKUMAR PALLAVUR V·Filed 2007·Application pending·0 cites
- 2444US2010215653A1Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Sievers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →